Correlation Between Sacral Angle and Lumbar Range of Motion in Women With Genu Valgum

May 5, 2020 updated by: Karima Abdelaty Hassan, Cairo University
Many patients with genu valgum present with postural changes, such as: internal rotation of the tibial and femoral axes, anteversion of the iliac bones, increased lumbar lordosis, thoracic hyperkyphosis and cervical hyperlordosis. Such pathomechanical changes may interfere with lumbar range of motion. Investigators of this study try to answer the following question: is there a relationship between sacral angle and lumbar range of motion in women with bilateral genu valgum. the results of this study will help professionals to plan a proper treatment program for patients with genu valgum.

Study Overview

Status

Completed

Conditions

Detailed Description

Sixty four female participants were under the following procedures:

  • Screening for genu valgum via postural assessment from frontal view, then measuring the Q angle bilaterally.
  • Patients with Q-angle >20 degress were under the following procedures:

A. Full-Length AP standing X-ray,then the investigators measured the hip-knee angle (the angle between the mechanical axis of the femur and the tibia). It will be obtained by connecting the center of the femoral head to the midpoint of the tibial eminential spine in a line tangential to the femoral condyles, and another line from here to the centre of the trochlea tali.

B-Lumbo-sacral X-ray lateral view was done at the time and the sacral angle was the measured by Ferguson´s technique in degrees using a protractor and this was the sacral angle.

C- During the same session, trunk range of motion was measured by Modified schober test D- Collected data were taken for statistical analysis.

Study Type

Observational

Enrollment (Actual)

64

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Giza, Egypt
        • Cairo University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 25 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Female with bilateral genu valgum with age range 18-25 and BMI≥ 30 (kg/m2)

Description

Inclusion Criteria:

  1. Female with bilateral genu valgum (Q angle> 20 degrees.
  2. Age ranges from 18-25 years old.
  3. BMI ≥ 30 (kg/m2)

Exclusion Criteria:

  1. Previous lumbar surgery
  2. lumbar spine fracture
  3. Spondylolisthesis
  4. Foraminal or extra foraminal lumbar disc herniation
  5. spinal tumors, and bone metabolic diseases 6 - Knee surgeries

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sacral angle
Time Frame: 30 minutes

After X-ray lateral view for lumbo-sacral spine, the investigators used a 30 cm long transparent ruler to measure the sacral angle on the X-ray film.

Two lines were drawn, the first line along the superior margin of the sacrum, and the second line was the horizontal line.

The acute angle between 2 lines(sacral angle) was measured in degrees using a protractor.

30 minutes
Lumbar range of motion measured by Modified Shobber test
Time Frame: 15 minutes
  • Patient was directed to stand with the back exposed.
  • Dimples of Venus (posterior superior iliac spine) was determined and was marked by pertinent marker.
  • Using tape measurement, the researcher marked a point 5 cm below and 10 cm above marked dimples (total marked area was 15 cm).
  • Then the subject was asked to lean forward without bending the knees.
  • The distance between 2 points was measured (D), then the ROM was determined by the following equation; ROM = D -15.
15 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

April 14, 2019

Primary Completion (ACTUAL)

August 15, 2019

Study Completion (ACTUAL)

September 5, 2019

Study Registration Dates

First Submitted

September 6, 2019

First Submitted That Met QC Criteria

May 5, 2020

First Posted (ACTUAL)

May 6, 2020

Study Record Updates

Last Update Posted (ACTUAL)

May 6, 2020

Last Update Submitted That Met QC Criteria

May 5, 2020

Last Verified

May 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • P.T.REC/012/002300

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Genu Valgum

3
Subscribe